Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,477,364
  • Shares Outstanding, K 15,050
  • Annual Sales, $ 2,264 M
  • Annual Income, $ 272,510 K
  • EBIT $ 427 M
  • EBITDA $ 488 M
  • 60-Month Beta 0.46
  • Price/Sales 3.67
  • Price/Cash Flow 22.51
  • Price/Book 6.73

Options Overview Details

View History
  • Implied Volatility 17.94% ( -1.03%)
  • Historical Volatility 41.62%
  • IV Percentile 60%
  • IV Rank 46.19%
  • IV High 25.06% on 10/31/24
  • IV Low 11.83% on 08/21/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 2
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 263
  • Open Int (30-Day) 318

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 6.34
  • Number of Estimates 2
  • High Estimate 6.39
  • Low Estimate 6.29
  • Prior Year 6.60
  • Growth Rate Est. (year over year) -3.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
523.33 +9.10%
on 11/04/24
613.78 -6.98%
on 10/29/24
-22.60 (-3.81%)
since 10/22/24
3-Month
523.33 +9.10%
on 11/04/24
615.65 -7.26%
on 10/18/24
-0.80 (-0.14%)
since 08/22/24
52-Week
523.33 +9.10%
on 11/04/24
654.62 -12.78%
on 03/15/24
-9.76 (-1.68%)
since 11/22/23

Most Recent Stories

More News
Insider Sale: executive vice president of $CHE (CHE) Sells 1,000 Shares

SPENCER S LEE, the executive vice president of $CHE ($CHE), sold 1,000 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.0%...

CHE : 570.96 (+1.36%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 570.96 (+1.36%)
Reasons to Retain Chemed Stock in Your Portfolio Now

Chemed Corporation CHE is expected to grow in the upcoming quarters, backed by the prospects of the VITAS business. Strength within the company’s Roto-rooter brand looks impressive. Meanwhile, Chemed’s...

AXGN : 13.34 (+1.83%)
CHE : 570.96 (+1.36%)
PAHC : 23.74 (-0.08%)
TMDX : 76.04 (-4.16%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 570.96 (+1.36%)
Chemed: Q1 Earnings Snapshot

Chemed: Q1 Earnings Snapshot

CHE : 570.96 (+1.36%)
Chemed: Q4 Earnings Snapshot

Chemed: Q4 Earnings Snapshot

CHE : 570.96 (+1.36%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 570.96 (+1.36%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 570.96 (+1.36%)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2023 Health Care Conference on Wednesday, May 10, 2023, at 10:40 AM (PDT) at the Encore...

CHE : 570.96 (+1.36%)
Chemed: Q1 Earnings Snapshot

Chemed: Q1 Earnings Snapshot

CHE : 570.96 (+1.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides...

See More

Key Turning Points

3rd Resistance Point 582.02
2nd Resistance Point 577.43
1st Resistance Point 574.19
Last Price 570.96
1st Support Level 566.36
2nd Support Level 561.77
3rd Support Level 558.53

See More

52-Week High 654.62
Fibonacci 61.8% 604.47
Fibonacci 50% 588.97
Fibonacci 38.2% 573.48
Last Price 570.96
52-Week Low 523.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar